2135 — Raily Aesthetic Medicine International Holdings Share Price
Last trade - 00:00- HK$59.05m
- HK$53.36m
- CNY189.41m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.45 | ||
| Price to Tang. Book | 0.75 | ||
| Price to Free Cashflow | 24.19 | ||
| Price to Sales | 0.23 | ||
| EV to EBITDA | 1.25 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 12.52% | ||
| Return on Equity | 12.88% | ||
| Operating Margin | 7.49% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 188.37 | 164.52 | 189.38 | 199.34 | 189.41 | n/a | n/a | 2.85% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Raily Aesthetic Medicine International Holdings Ltd is an investment holding company primarily engaged in the provision of aesthetic medical services. The Company's main business is to provide customers with aesthetic medical services, including aesthetic surgery services, minimally-invasive aesthetic services and aesthetic dermatology services. The Company operates its businesses through three business segments. The Aesthetic Medical Services segment comprises principally inpatient services including surgical services and outpatient services including injection service, dermatology service and others. The Consulting Services segment comprises principally management consulting services. The Aesthetic Medical Equipment Products segment comprises principally sales of collagen injection products, surgical implants and aesthetic medical skincare products. The Company mainly conducts its businesses within domestic market.
Directors
- Last Annual
- December 31st, 2025
- Last Interim
- June 30th, 2026
- Incorporated
- January 2nd, 2018
- Public Since
- December 28th, 2020
- No. of Employees
- 258
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 557,077,333
- Address
- No. 290 North Zhongshan Road, HANGZHOU
- Web
- http://www.raily.com/
- Phone
- Auditors
- Ernst & Young
Latest News for 2135
Upcoming Events for 2135
Similar to 2135
Adicon Holdings
Stock Exchange of Hong Kong Limited
Arrail
Stock Exchange of Hong Kong Limited
Suzhou Basecare Medical
Stock Exchange of Hong Kong Limited
Bayzed Health
Stock Exchange of Hong Kong Limited
BenQ BM Holding Cayman
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 04:54 UTC, shares in Raily Aesthetic Medicine International Holdings are trading at HK$0.11. This share price information is delayed by 15 minutes.
Shares in Raily Aesthetic Medicine International Holdings last closed at HK$0.11 and the price had moved by -4.5% over the past 365 days. In terms of relative price strength the Raily Aesthetic Medicine International Holdings share price has underperformed the FTSE Developed Asia Pacific Index by -30.25% over the past year.
There is no consensus recommendation for this security.
Find out moreRaily Aesthetic Medicine International Holdings does not currently pay a dividend.
Raily Aesthetic Medicine International Holdings does not currently pay a dividend.
Raily Aesthetic Medicine International Holdings does not currently pay a dividend.
To buy shares in Raily Aesthetic Medicine International Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$0.11, shares in Raily Aesthetic Medicine International Holdings had a market capitalisation of HK$59.05m.
Here are the trading details for Raily Aesthetic Medicine International Holdings:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 2135
Based on an overall assessment of its quality, value and momentum Raily Aesthetic Medicine International Holdings is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Raily Aesthetic Medicine International Holdings. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -29.42%.
As of the last closing price of HK$0.11, shares in Raily Aesthetic Medicine International Holdings were trading -18.51% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Raily Aesthetic Medicine International Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.11.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Raily Aesthetic Medicine International Holdings' directors